- Display 15 Products per page
Published: April 1, 2004 | Price: $1,995.00 – $3,990.00
The recent terrorism events, in addition to the ease of travel that allows infectious diseases to spread, and technology developments drive the renewed interest in clinical and environmental infectious disease diagnostics. The combined public health and bio-terrorism markets of several bacterial and protozoan diseases are estimated to be nearly $100 million. This report, the final volume of the Diagnostics for Emerging Infectious Disease Threats series, focuses on diagnostic testing for 11 bacterial and protozoal diseases in clinical and environmental testing:...Published: November 1, 2008 | Price: $1,990.00 – $2,000.00
This report takes a bold look into the world glucose testing, ten years from now. It is not an exercise in crystal ball gazing. Rather, in this report, Kalorama offers a calculated look into the future, based on events taking place in the present. The report offers a quantitative assessment of specific markets, worldwide, in US dollars for 2007 to 2012. With the reported growing epidemic of diabetes, worldwide, it is widely held that glucose self testing and diabetes management...Published: January 10, 2017 | Price: $796.00 – $1,592.00
Mergers and Acquisitions in the IVD Market Mergers and Acquisitions (M&A) activity in the in vitro diagnostics (IVD) market was brisk in 2016. Kalorama's report records 250 acquisitions in the industry from 2013-2016. Becton Dickinson (BD), Danaher, Roche, and Thermo Fisher Scientific were among the companies active in M&A during this period.Published: January 26, 2016 | Price: $796.00 – $1,592.00
Point of Care (POC) Cholesterol Testing Market Point of Care (POC) Cholesterol Testing Market presents the revenue picture for cholesterol testing performed at or near the site where the patient is located. The following data regarding the POC cholesterol market are provided: world POC cholesterol testing revenue estimates, 2012-2020; POC cholesterol self-testing revenue estimates, 2015 and 2020; POC cholesterol professional testing revenue estimates, 2015 and 2020; world POC cholesterol testing revenue estimates and market share of leading manufacturers, 2014; and...Published: October 25, 2018 | Price: $1,500.00 – $3,000.00
This brief report contains Kalorama Information's estimates of European in vitro diagnostics markets including current (2018) country level estimates and forecasts. Content for this report is based on information in The Worldwide Market for In Vitro Diagnostic Tests, 11th Edition, with additional forecasting information.Published: March 28, 2018 | Price: $1,500.00 – $3,000.00
Convenience clinics are designed to occupy small spaces and provide just basic care. Therefore, they do not use most of the sophisticated medical equipment found in hospitals or specialty centers such as advanced imaging devices. In fact, while a few larger centers have x-ray machines, most do not. However, retail clinics are becoming relatively large users of point-of-care (POC) tests, clinical chemistry and immunoassay laboratory tests and vaccines. This chapter examines the effect of retail clinics on each of these...Published: March 21, 2018 | Price: $1,500.00 – $3,000.00
This report provides market estimates and forecasts for point-of-care glucose testing. Information in this report is from the latest published figures for companies participating in the market as well as recent interviews. The following markets analysis is provided in this report: Global POC Glucose Testing Market Analysis, 2015-2022 (in millions of dollars at the manufacturer’s level) POC Blood Glucose Testing Regional Market Analysis, 2017 (US, Europe, Asia, ROW) Global POC Glucose Self-Testing Market (includes continuous glucose devices) ...Published: September 13, 2013 | Price: $1,500.00 – $3,000.00
Brazil is the fifth largest country in the world, after Russia, Canada, China and the United States. The size of the country as made it a focus for IVD companies. This report, The IVD Market in Brazil, provides market estimates and forecasts for the main categories of in vitro diagnostics, and forecasts those markets to 2017. Information was obtained by both primary and secondary sources. Annual reports, trade publications, as well as telephone and email surveys of IVD manufacturers operating...Published: March 1, 2011 | Price: $1,500.00 – $2,500.00
This bundle provides customers with three of the most intensely researched Kalorama Information reports covering the diagnostic industry authored by Shara Rosen, R.T., M.B.A. in 2010 and 2011 These reports will be provided in one PDF, each with its own table of contents. The bundle allows customers to save almost $4,500 off the cost of the individual reports. THE WORLDWIDE MARKET FOR IN VITRO DIAGNOSTIC TESTS, 7th Edition This 900 page report contains coverage of all segments of In Vitro...Published: April 1, 2009 | Price: $1,500.00 – $9,990.00
From Kalorama Information a unique tool for assessing the diagnostic business today. Working in conjunction with premier diagnostic survey database Emmes Group, Kalorama Information presents the summarized results from a recent survey of a critical mass of diagnostic labs in the U.S, with analysis from Kalorama's leading diagnostic analyst, Shara Rosen. Far more than any other market research report, this report provides the most current and accurate picture of what is truly going on in molecular diagnostics in the United...Published: February 1, 2009 | Price: $1,500.00 – $7,000.00
The reinvigorated market for medical imaging systems employing x-rays has undoubtedly been propelled by the explosion of digital technology. But also, the expanded role of imaging modalities in a whole host of clinical applications from trauma to cancer to cardiology has increased the profile of radiography while enabling computer technologies expand the usefulness of traditional x-ray techniques. Kalorama's Medical Imaging Markets Volume I: Radiography analyzes the current and potential world market for medical x-ray systems, including several distinct imaging modalities...Published: August 1, 2008 | Price: $1,500.00 – $7,000.00
Test services, once the norm in the diagnostics industry, then abandoned for reagent sales, are now making a comeback. IVD companies have established cGMP and CLIA-registered labs by which they offer their proprietary tests to physicians, hospitals and reference labs. These tests are outside the oversight of the traditional FDA and CE Mark test commercialization avenue in the U.S, and Europe and so are thought to come to market by what may seem to be the back door. Kalorama has...Published: August 1, 2008 | Price: $1,500.00 – $7,000.00
The benefits of automation in the clinical laboratory are well documented. They involve replacing manual, potentially dangerous, error-prone steps with automated processes requiring minimal operator intervention. This approach can increase productivity, decrease turnaround time, improve staff safety, minimize errors, improve the handling of specimens, and allow labs to reallocate personnel to more important and productive tasks. For drug discovery, automation also offers benefits. bringing a new drug to market has been both a very time-intensive, laborious and expensive undertaking. This...Published: November 1, 2006 | Price: $1,500.00 – $5,990.00
This report takes a bold look into the markets, technologies, and trends in decentralized testing with a special focus on the economics of rapid test use in critical care and emergency medicine. There is also an emphasis on early disease detection via rapid test use in clinics and public venues. The report is conservative in its predictions and offers a calculated look into the future, based on events currently taking place. The field for rapid test devices is crowded; worldwide,...Published: December 1, 2003 | Price: $1,496.00 – $2,992.00
Severe Acute Respiratory Syndrome (SARS), which was a new and unidentified disease when it first affected people, ripped through Asia and Toronto from late 2002 into the summer of 2003, before being contained for the season. Taiwan with just 346 reported cases performed 10,000 diagnostic tests. Three years after West Nile Virus (WNV) first appeared in the United States in 1999 with just 62 cases and 7 deaths, the U.S. Center for Disease Control reports thousands of cases and 150...